Enfermedad de Chagas aguda, en un adulto tratado con benznidazol (Rochagan) en Costa Rica
Montenegro, Víctor M; Castro Ugalde, Jorge A; Zeledón, Rodrigo.
Acta méd. costarric
; 46(2): 91-93, abr.-jun. 2004. ilus
Artigo em Espanhol | LILACS | ID: lil-400978
Documentos relacionados
Metacyclogenesis as the Starting Point of Chagas Disease.
Lizards as Silent Hosts of Trypanosoma cruzi.
Why do we still have not a vaccine against Chagas disease?
Shelter selection in the kissing bugs Triatoma infestans and Rhodnius prolixus: Intra- and inter-specific interactions and quality evaluation.
Overexpression of <i>TcNTPDase-1</i> Gene Increases Infectivity in Mice Infected with <i>Trypanosoma cruzi</i>.
Extracellular Vesicles: Translational Agenda Questions for Three Protozoan Parasites.
Cytokine profile levels and their relationship with parasitemia and cardiomyopathy in people with Chagas disease in Spain. A prospective observational study.
Direct evidence gap on fixed versus adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta-analysis.
Population movements, borders, and Chagas disease.
Cell invasion by intracellular parasites - the many roads to infection.